(19)
(11) EP 4 399 523 A1

(12)

(43) Date of publication:
17.07.2024 Bulletin 2024/29

(21) Application number: 22868251.4

(22) Date of filing: 07.09.2022
(51) International Patent Classification (IPC): 
G01N 33/52(2006.01)
A61P 13/12(2006.01)
A61K 38/22(2006.01)
A61P 9/12(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 9/12; A61P 13/12; G01N 33/5041; G01N 2800/32; A61K 38/2242
(86) International application number:
PCT/US2022/076008
(87) International publication number:
WO 2023/039392 (16.03.2023 Gazette 2023/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.09.2021 US 202163241484 P

(71) Applicant: Mayo Foundation for Medical Education and Research
Rochester, Minnesota 55905 (US)

(72) Inventors:
  • ZHENG, Ye
    Rochester, Minnesota 55901 (US)
  • IYER, Seethalakshmi R.
    Rochester, Minnesota 55901 (US)
  • BURNETT, John C., Jr.
    St. Anthony, Minnesota 55902 (US)
  • SANGARALINGHAM, Sasantha J.
    Rochester, Minnesota 55902 (US)

(74) Representative: Fish & Richardson P.C. 
Highlight Business Towers Mies-van-der-Rohe-Straße 8
80807 München
80807 München (DE)

   


(54) METHODS AND MATERIALS FOR DETERMINING PGC TARGET DOSAGE